An active metabolite of ifosfamide
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Palifosfamide

Item No. 29887

Technical Information
Formal Name
N,N′-bis(2-chloroethyl)-phosphorodiamidic acid
CAS Number
31645-39-3
Synonyms
  • Isophosphoramide Mustard
  • NSC 297900
Molecular Formula
C4H11Cl2N2O2P
Formula Weight
Purity
≥95%
A crystalline solid
DMF: 30 mg/mlDMSO: 30 mg/ml
SMILES
ClCCNP(NCCCl)(O)=O
InChi Code
InChI=1S/C4H11Cl2N2O2P/c5-1-3-7-11(9,10)8-4-2-6/h1-4H2,(H3,7,8,9,10)
InChi Key
BKCJZNIZRWYHBN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Palifosfamide is an active metabolite of the DNA alkylating agent ifosfamide (Item No. 17562).1 Palifosfamide is formed through hydroxylation of ifosfamide by various hepatic cytochrome P450 (CYP) isoforms.2 It is cytotoxic to L1210 and CCRF-CEM cancer cells when used at a concentration of 100 µM.3 Palifosfamide (100 mg/kg per day) reduces tumor growth in murine Lewis lung carcinoma and L1210 leukemia models, as well as a rat Yoshida ascitic sarcoma model.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. R.F., S., Dykes, D.J., Corbett, T.H., et alIsophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide. Br. J. Cancer 47(1), 15-26 (1983).

    2. Lowenberg, D., Thorn, C.F., Desta, S., et alPharmGKB summary: ifosfamide pathways, pharmacokinetics and pharmacodynamics. Pharmacogenet. Genom. 24(2), 133-138 (2014).

    3. Zheng, J.J., Chan, K.K., and Muggia, F. Preclinical pharmacokinetics and stability of isophosphoramide mustard. Cancer Chemother. Pharmacol. 33(5), 391-398 (1994).